Katherine Yang, PharmD, MPH

Professor

Infectious Diseases

Kathy Yang, Pharm.D., MPH is a Health Sciences Clinical Professor in the Department of Clinical Pharmacy at the University of California (UCSF) School of Pharmacy and an Infectious Diseases Clinical Pharmacist in the UCSF Medical Center. Dr. Yang specializes in the treatment of multi-drug resistant infections, particularly gram negative bacteria such as Pseudomonas aeruginosa. Her area of research focuses on the pharmacodynamic optimization of antibiotics for the treatment of biofilm-mediated infections such as cystic fibrosis.

Within the School of Pharmacy, Dr. Yang is involved in multiple aspects of the curriculum related to infectious diseases. Dr. Yang is also the co-director of Foundations, the first course of the Pharm.D. curriculum.

Education
MPH, 2001 - Public Health, University of California, Berkeley
Residency in Infectious Diseases, 2000 - Infectious diseases, University of California, San Francisco
Residency in Pharmacy Practice, 1999 - Pharmacy, University of California, San Francisco
Pharm.D., 1998 - Pharmacy, University of California, San Francisco
Honors and Awards
  • Fellow, California Society of Health-Systems Pharmacists, 2006
  • Long Prize for Excellence in Teaching, UCSF School of Pharmacy, 2005
Websites
Publications

  1. Highet A, Kendrick DE, Bandeh-Ahmadi H, Vitous A, Yang K, Ernst C, George BC. Pragmatic Mentoring Strategies for the Busy Surgeon Scientist. TO REMOVE 2022. PMID: 35144902


  2. Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB. Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infection control and hospital epidemiology 2021. PMID: 33487182


  3. Yang K. What do we know about remdesivir drug interactions? Clinical and translational science 2020. PMID: 32402130


  4. Huang L, Haagensen JAJ, Verotta D, Cheah V, Spormann AM, Aweeka F, Yang K. Determination of Tobramycin in M9 Medium by LC-MS/MS: Signal Enhancement by Trichloroacetic Acid. Journal of analytical methods in chemistry 2018. PMID: 29854560


  5. Verotta D, Haagensen J, Spormann AM, Yang K. Mathematical Modeling of Biofilm Structures Using COMSTAT Data. Computational and mathematical methods in medicine 2017. PMID: 29422943


  6. Haagensen J, Verotta D, Huang L, Engel J, Spormann AM, Yang K. Spatiotemporal pharmacodynamics of meropenem- and tobramycin-treated Pseudomonas aeruginosa biofilms. The Journal of antimicrobial chemotherapy 2017. PMID: 28961810


  7. Trang TP, Hanretty AM, Langelier C, Yang K. Use of isavuconazole in a patient with voriconazole-induced QTc prolongation. Transplant infectious disease : an official journal of the Transplantation Society 2017. PMID: 28434195


  8. Haagensen JA, Verotta D, Huang L, Spormann A, Yang K. New in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms. Antimicrobial agents and chemotherapy 2015. PMID: 25918138


  9. Huang L, Haagensen J, Verotta D, Lizak P, Aweeka F, Yang K. Determination of meropenem in bacterial media by LC-MS/MS. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2014. PMID: 24861874


  10. Fricks-Lima J, Hendrickson CM, Allgaier M, Zhuo H, Wiener-Kronish JP, Lynch SV, Yang K. Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Volume 37 of Issue 4. International journal of antimicrobial agents 2011. PMID: 21382698


  11. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. American journal of infection control 2010. PMID: 20605267


  12. Yang, K
    MacDougall C
    Wiener-Kronish J. An Evidenced-based Practice in Critical Care Epidemiology and management of antibiotic resistance in the ICU 2010. PMID:


  13. Steinman MA, Yang KY, Byron SC, Maselli JH, Gonzales R. Variation in outpatient antibiotic prescribing in the United States. The American journal of managed care 2009. PMID: 20001167


  14. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. The Annals of pharmacotherapy 2008. PMID: 19033484


  15. Zhuo H, Yang K, Lynch SV, Dotson RH, Glidden DV, Singh G, Webb WR, Elicker BM, Garcia O, Brown R, Sawa Y, Misset B, Wiener-Kronish JP. Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Volume 36 of Issue 9. Critical care medicine 2008. PMID: 18679122


  16. Lynch SV
    Yang K
    Brodie EL
    MacDougall C
    Andersen G
    Wiener-Kronish JP. Culture-Independent Bacterial Population Analysis - Clinical Implications for Respiratory and Other Infections Current respiratory medicine reviews 2008. PMID:


  17. Yang K, Guglielmo BJ. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. The Annals of pharmacotherapy 2007. PMID: 17666573


  18. Yang K
    Youmans S. Expanding the Role of the Pharmacist in Public Health California Journal of Health-Systems Pharmacy 2006. PMID:


  19. Youmans S
    Vogt E
    Yang K. Utilization of Community Pharmacies: Implications for Health Care Delivery Harvard Health Policy Review 2006. PMID:


  20. Yang K
    Graff L
    Caughey A. Blueprints Notes and Cases Pharmacology 2003. PMID:


  21. Yang K, Guglielmo BJ. Patient education for H pylori: who benefits? The Western journal of medicine 2002. PMID: 11897729